$ILAL
International Land Alliance Inc. Stock $ilal

$ilal Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223029488 Filed on August 21, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q4
Revenue	$358.1K	$485.6K	$0.00
YoY Change	2009.99%	2760.9%	-100.0%
Cost Of Revenue	$296.7K	$999.00	$0.00
YoY Change			-100.0%
Gross Profit	$61.45K	$484.6K	$0.00
YoY Change	262.04%	2755.01%	-100.0%
Gross Profit Margin	17.16%	99.79%
Selling, General & Admin	$1.019M	$727.8K	$4.193M
YoY Change	91.18%	-51.87%	186.28%
% of Gross Profit	1658.33%	150.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$29.75K	$29.75K	$13.23K
YoY Change	124.68%	122.48%	-7.87%
% of Gross Profit	48.41%	6.14%
Operating Expenses	$1.019M	$727.8K	$4.193M
YoY Change	91.18%	-51.87%	186.28%
Operating Profit	-$957.6K	-$243.2K	-$4.193M
YoY Change	85.56%	-83.74%	304.88%
Interest Expense	$708.4K	$431.4K	-$1.989M
YoY Change	12.2%	91.87%	374.48%
% of Operating Profit
Other Income/Expense, Net	-$5.383M	-$135.5K	$540.00
YoY Change	1065.13%	-62.91%
Pretax Income	-$6.340M	-$378.7K	-$10.42M
YoY Change	548.23%	-79.65%	616.14%
Income Tax
% Of Pretax Income
Net Earnings	-$6.340M	-$378.7K	-$10.42M
YoY Change	548.26%	-79.65%	616.14%
Net Earnings / Revenue	-1770.41%	-77.98%
Basic Earnings Per Share	-$0.11	-$0.01
Diluted Earnings Per Share	-$0.11	-$0.01	-$0.29
COMMON SHARES
Basic Shares Outstanding	64.94M shares	64.94M shares	36.80M shares
Diluted Shares Outstanding	64.44M shares	61.93M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$120.0K	$52.04K	$49.37K
YoY Change	25.21%	841.05%	-12.76%
Cash & Equivalents	$123.1K	$52.04K	$49.37K
Short-Term Investments
Other Short-Term Assets	$20.00K	$8.840K	$49.20K
YoY Change	-90.3%	-95.64%	-80.45%
Inventory
Prepaid Expenses
Receivables	$1.652M	$1.674M	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.792M	$1.735M	$98.57K
YoY Change	401.37%	224.04%	-84.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.815M	$3.237M	$1.069M
YoY Change	-23.7%	43.0%	-45.84%
Goodwill	$22.36M
YoY Change
Intangibles
YoY Change
Long-Term Investments			$0.00
YoY Change			-100.0%
Other Assets	$50.38K	$49.71K	$0.00
YoY Change	-92.22%	-92.32%
Total Long-Term Assets	$25.44M	$3.287M	$1.069M
YoY Change	346.33%	-38.54%	-79.58%
TOTAL ASSETS
Total Short-Term Assets	$1.792M	$1.735M	$98.57K
Total Long-Term Assets	$25.44M	$3.287M	$1.069M
Total Assets	$27.23M	$5.022M	$1.168M
YoY Change	349.58%	-14.64%	-80.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.960M	$1.771M	$864.5K
YoY Change	10.11%	11.59%	-47.81%
Accrued Expenses	$1.820M	$844.5K	$485.7K
YoY Change
Deferred Revenue	$93.38K	$93.38K	$85.41K
YoY Change	-80.85%	-71.74%	-32.57%
Short-Term Debt	$9.547M	$9.547M	$1.845M
YoY Change	635.02%	867.82%	121.01%
Long-Term Debt Due	$2.290M	$1.890M	$1.886M
YoY Change	3.67%	-9.9%	1734.97%
Total Short-Term Liabilities	$34.21M	$32.47M	$5.719M
YoY Change	465.08%	546.55%	108.64%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.21M	$32.47M	$5.719M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$34.21M	$32.47M	$5.719M
YoY Change	465.08%	546.55%	27.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$33.70M	-$27.90M	-$25.10M
YoY Change	77.37%	54.14%	70.7%
Common Stock	$75.40K	$64.94K	$43.50K
YoY Change	106.72%	79.71%	36.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$300.0K	$300.0K
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.587M	-$28.05M	-$4.551M
YoY Change
Total Liabilities & Shareholders Equity	$27.23M	$5.022M	$1.168M
YoY Change	349.58%	-14.64%	-80.07%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q4
OPERATING ACTIVITIES
Net Income	-$6.340M	-$378.7K	-$10.42M
YoY Change	548.26%	-79.65%	616.14%
Depreciation, Depletion And Amortization	$29.75K	$29.75K	$13.23K
YoY Change	124.68%	122.48%	-7.87%
Cash From Operating Activities	-$820.0K	-$325.5K	-$22.02K
YoY Change	366.31%	-2306.58%	-93.37%
INVESTING ACTIVITIES
Capital Expenditures	$200.0K	$35.33K	$95.40K
YoY Change	-256.01%	-117.04%	-133.98%
Acquisitions
YoY Change
Other Investing Activities	$210.0K	$0.00	$0.00
YoY Change
Cash From Investing Activities	$10.00K	-$35.33K	-$95.40K
YoY Change	-107.8%	-82.96%	-66.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	880.0K	213.4K	70.95K
YoY Change	123.15%	4309.92%	-319.8%
NET CHANGE
Cash From Operating Activities	-820.0K	-325.5K	-22.02K
Cash From Investing Activities	10.00K	-35.33K	-95.40K
Cash From Financing Activities	880.0K	213.4K	70.95K
Net Change In Cash	70.00K	-147.4K	-46.47K
YoY Change	-22.49%	-21.51%	-92.8%
FREE CASH FLOW
Cash From Operating Activities	-$820.0K	-$325.5K	-$22.02K
Capital Expenditures	$200.0K	$35.33K	$95.40K
Free Cash Flow	-$1.020M	-$360.8K	-$117.4K
YoY Change	2040.61%	-262.46%	127.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
	ILAL	Increase Decrease In Accounts Payable And Accrued Interestrelated Party IncreaseDecreaseInAccountsPayableAndAccruedInterestrelatedParty		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001657214
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent		usd
CY2022Q4	ILAL	Convertible Note Acquisition Related Party ConvertibleNoteAcquisitionRelatedParty		usd
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent		usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther		usd
	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2023Q2	ILAL	Stock Issued During Period Value Stock Warrant Exercised StockIssuedDuringPeriodValueStockWarrantExercised		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	ILAL	Excess Fair Value Of Derivative Over Carrying Balance Of Debt ExcessFairValueOfDerivativeOverCarryingBalanceOfDebt		usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet		usd
	ILAL	Increase Decrease In Accrued Interest On Note Receivable IncreaseDecreaseInAccruedInterestOnNoteReceivable		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse		usd
	ILAL	Series C Preferred Stock Issued For Cash SeriesCPreferredStockIssuedForCash		usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	ILAL	Dividend On Series C DividendOnSeriesC		usd
	ILAL	Common Shares Issued With Convertible Debt CommonSharesIssuedWithConvertibleDebt		usd
	ILAL	Common Stock Issued For Finders Fee Agreement CommonStockIssuedForFindersFeeAgreement		usd
	ILAL	Debt Discount Created From Warrants Embedded In Financing DebtDiscountCreatedFromWarrantsEmbeddedInFinancing		usd
	ILAL	Corporate Expenses Paid By Related Party Note CorporateExpensesPaidByRelatedPartyNote		usd
	ILAL	Common Shares Issued For Services CommonSharesIssuedForServices		usd
CY2022Q2	us-gaap	Share Price SharePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate		pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate		pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56111
	dei	Entity Registrant Name EntityRegistrantName	INTERNATIONAL LAND ALLIANCE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3752361
	dei	Entity Address Address Line1 EntityAddressAddressLine1	350 10th Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1000
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92101
	dei	City Area Code CityAreaCode	(877)
	dei	Local Phone Number LocalPhoneNumber	661-4811
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	64943897	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52038	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49374	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1674351	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8835	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	49198	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1735224	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	98572	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	49711	usd
CY2023Q2	us-gaap	Land Land	1387065	usd
CY2022Q4	us-gaap	Land Land	203419	usd
CY2023Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1841991	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	863745	usd
CY2023Q2	ILAL	Furniture And Equipment Net FurnitureAndEquipmentNet	8269	usd
CY2022Q4	ILAL	Furniture And Equipment Net FurnitureAndEquipmentNet	1877	usd
CY2023Q2	us-gaap	Assets Assets	5022260	usd
CY2022Q4	us-gaap	Assets Assets	1167613	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1427736	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	675202	usd
CY2023Q2	ILAL	Accounts Payable And Accrued Liabilities Related Party AccountsPayableAndAccruedLiabilitiesRelatedParty	343728	usd
CY2022Q4	ILAL	Accounts Payable And Accrued Liabilities Related Party AccountsPayableAndAccruedLiabilitiesRelatedParty	189266	usd
CY2023Q2	us-gaap	Deferred Income Current DeferredIncomeCurrent	9558366	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	639414	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	352884	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	205033	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	132841	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	93382	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	85407	usd
CY2023Q2	us-gaap	Deposits Deposits	20500	usd
CY2022Q4	us-gaap	Deposits Deposits	20500	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	626792	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	531527	usd
CY2023Q2	ILAL	Convertible Notes Net Of Debt Discounts ConvertibleNotesNetOfDebtDiscounts	583678	usd
CY2022Q4	ILAL	Convertible Notes Net Of Debt Discounts ConvertibleNotesNetOfDebtDiscounts	558657	usd
CY2023Q2	ILAL	Convertible Note Acquisition Related Party ConvertibleNoteAcquisitionRelatedParty	8900000	usd
CY2023Q2	ILAL	Promissory Notes Payable Current PromissoryNotesPayableCurrent	1889762	usd
CY2022Q4	ILAL	Promissory Notes Payable Current PromissoryNotesPayableCurrent	1885616	usd
CY2023Q2	ILAL	Promissory Notes Payable Related Parties Current PromissoryNotesPayableRelatedPartiesCurrent	1599824	usd
CY2022Q4	ILAL	Promissory Notes Payable Related Parties Current PromissoryNotesPayableRelatedPartiesCurrent	1286695	usd
CY2023Q2	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	6579842	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	32468056	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5718595	usd
CY2023Q2	us-gaap	Liabilities Liabilities	32468056	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5718595	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	603500	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2010000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2010000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64943897	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61943897	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43499423	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43499423	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	64944	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	43500	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	36281	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20233446	usd
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3000000	shares
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	300000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27850553	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25121457	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-28049295	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4844482	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5022260	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1167613	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	485580	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16973	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	726512	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33946	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	999	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	484581	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	16973	usd
	us-gaap	Gross Profit GrossProfit	722512	usd
	us-gaap	Gross Profit GrossProfit	33946	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28175	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	772405	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	288259	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	802683	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	245674	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	699597	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	739801	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1309777	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2073747	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	727772	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1512206	usd
	us-gaap	Operating Expenses OperatingExpenses	1843710	usd
	us-gaap	Operating Expenses OperatingExpenses	2876430	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-243191	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1495233	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1121198	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2842484	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-49329	usd
CY2023Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	295901	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-101777	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-140989	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-182093	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	536	usd
	us-gaap	Interest Income Other InterestIncomeOther	536	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	431369	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	224821	usd
	us-gaap	Interest Expense InterestExpense	1014916	usd
	us-gaap	Interest Expense InterestExpense	329188	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-135468	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-365274	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1166022	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-510745	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-378660	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1860507	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2287221	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3353229	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	60003	usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	15000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	75003	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	30000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-438663	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1935510	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2302221	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3383229	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61929046	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61929046	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35452918	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35452918	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63973603	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63973603	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34164313	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34164313	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4844482	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1800000	usd
CY2023Q1	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	2674976	usd
CY2023Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	25354972	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	300000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	147805	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	15000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78047	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1908561	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-27707187	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18504	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78047	usd
CY2023Q2	ILAL	Stock And Warrants Issued During Period Value Preferred Stock StockAndWarrantsIssuedDuringPeriodValuePreferredStock	3100	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-60003	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-378660	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-28049295	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1088833	usd
CY2022Q1	ILAL	Stock Issued During Period Value Issued From Promissory Notes StockIssuedDuringPeriodValueIssuedFromPromissoryNotes	202275	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	600	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	447278	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	871688	usd
CY2022Q1	ILAL	Stock Issued During Period Value Warrants Issued In Connection With Promissory Notes StockIssuedDuringPeriodValueWarrantsIssuedInConnectionWithPromissoryNotes	159664	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1492722	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1262616	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1262616	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	40490	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	700	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	729885	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	410288	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1860507	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	568472	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	568472	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2287221	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3353229	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	174598	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1281976	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	245674	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	15000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1177163	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-49329	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	59494	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26472	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-182093	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	203607	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	144935	usd
	ILAL	Excess Fair Value Of Derivative Over Carrying Balance Of Debt ExcessFairValueOfDerivativeOverCarryingBalanceOfDebt	36062	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-101777	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-51666	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13199	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-40363	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-48993	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	7138	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	694	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-25219	usd
	ILAL	Increase Decrease In Accounts Payable And Accrued Interestrelated Party IncreaseDecreaseInAccountsPayableAndAccruedInterestrelatedParty	154462	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	281746	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-498803	usd
	ILAL	Increase Decrease In Accrued Interest On Note Receivable IncreaseDecreaseInAccruedInterestOnNoteReceivable	3946	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	92595	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	203770	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-288488	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-330191	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	321919	usd
	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	250596	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	179700	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	316335	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-108377	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-316335	usd
	ILAL	Common Stock Issued From Options Exercise CommonStockIssuedFromOptionsExercise	1300	usd
	ILAL	Series C Preferred Stock Issued For Cash SeriesCPreferredStockIssuedForCash	250000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	228190	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	192244	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	91513	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	51128	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	100000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	522500	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	25052	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	344180	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	315042	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	399529	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	595470	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2664	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-51056	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49374	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56590	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52038	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5534	usd
	us-gaap	Interest Paid Net InterestPaidNet	47285	usd
	us-gaap	Interest Paid Net InterestPaidNet	75858	usd
	ILAL	Dividend On Series B DividendOnSeriesB	15000	usd
	ILAL	Dividend On Series B DividendOnSeriesB	30000	usd
	ILAL	Dividend On Series C DividendOnSeriesC	60003	usd
	ILAL	Common Shares Issued With Convertible Debt CommonSharesIssuedWithConvertibleDebt	202275	usd
	ILAL	Common Stock Issued For Finders Fee Agreement CommonStockIssuedForFindersFeeAgreement	40490	usd
	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes	104250	usd
	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes	93700	usd
	ILAL	Debt Discount Created From Warrants Embedded In Financing DebtDiscountCreatedFromWarrantsEmbeddedInFinancing	159664	usd
	ILAL	Corporate Expenses Paid By Related Party Note CorporateExpensesPaidByRelatedPartyNote	28665	usd
	ILAL	Common Shares Issued For Services CommonSharesIssuedForServices	15000	usd
CY2021Q2	us-gaap	Area Of Land AreaOfLand	1100
CY2023Q2	ILAL	Working Capital WorkingCapital	30700000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2300000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27900000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84E_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zC6weDwwaP6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zrU4uI3fKr48">Reclassification</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain numbers from 2022 have been reclassified to conform with the current year presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_z4Ek41YAHKx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zFzE6qAMJdY6">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management regularly evaluates estimates and assumptions related to the valuation of assets and liabilities. Management bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from management’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">■</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability for legal contingencies.</span></td></tr></table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">■</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful life of buildings.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">■</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions used in valuing equity instruments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">■</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes and related valuation allowances.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">■</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going concern.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">■</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assessment of long-lived assets for impairment.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">■</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant influence or control over the Company’s investee.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">■</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue recognition.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	726512	usd
CY2023Q2	ILAL	Notes Payable Gross NotesPayableGross	1889762	usd
CY2023Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	626792	usd
CY2023Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	626792	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	531527	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	136062	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements	-142574	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-397678	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	922693	usd
CY2023Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	295901	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	626792	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	-0	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	-0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7717500	shares
CY2022Q4	ILAL	Notes Payable Gross NotesPayableGross	1889762	usd
CY2023Q2	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P20Y
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	485580	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	28175	usd
CY2022Q2	us-gaap	Advertising Expense AdvertisingExpense	772405	usd
	us-gaap	Advertising Expense AdvertisingExpense	288259	usd
	us-gaap	Advertising Expense AdvertisingExpense	802683	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	44107500	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zCR9oaz8epbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zcJOueScPUMf">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2019Q1	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	1122050	usd
CY2019Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	271225	usd
CY2019Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	850826	usd
CY2023Q2	ILAL	Unpaid Amount Owed UnpaidAmountOwed	58560	usd
CY2022Q4	ILAL	Unpaid Amount Owed UnpaidAmountOwed	58560	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	749430	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	184393	usd
CY2023Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1841991	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	863745	usd
CY2023Q2	us-gaap	Depreciation Depreciation	29746	usd
CY2022Q2	us-gaap	Depreciation Depreciation	13370	usd
	us-gaap	Depreciation Depreciation	59494	usd
	us-gaap	Depreciation Depreciation	26472	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	4146	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	1889762	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	1885616	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1889762	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1885616	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	9547023	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	771738	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	63345	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	213081	usd
CY2023Q2	us-gaap	Convertible Debt ConvertibleDebt	9483678	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	558657	usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	9483678	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	558657	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	8900000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5328126	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q2	us-gaap	Area Of Land AreaOfLand	20
CY2023Q2	ILAL	Net Budget NetBudget	1556000	usd
CY2023Q2	ILAL	Net Budget Inclusive Of Lots Construction NetBudgetInclusiveOfLotsConstruction	995747	usd
CY2023Q2	us-gaap	Other Commitment OtherCommitment	560250	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2010000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64943897	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61943897	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43499423	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43499423	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	18504	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3867500	shares
CY2022Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.71
CY2022	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning	P4Y1M9D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	34740000	shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	0.10
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted	P4Y9M
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	38607500	shares
CY2023Q2	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.16
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning	P4Y5M1D
CY2023Q2	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	38607500	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.34
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M17D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.34
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M20D

Files In Submission

Name	View Source	Status
0001493152-23-029488-index-headers.html	Edgar Link	pending
0001493152-23-029488-index.html	Edgar Link	pending
0001493152-23-029488.txt	Edgar Link	pending
0001493152-23-029488-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
ilal-20230630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ilal-20230630_cal.xml	Edgar Link	unprocessable
ilal-20230630_def.xml	Edgar Link	unprocessable
ilal-20230630_lab.xml	Edgar Link	unprocessable
ilal-20230630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ILAL
International Land Alliance Inc. Stock $ilal

2023 Q3 Form 10-Q Financial Statement

#000149315223029488 Filed on August 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL International Land Alliance Inc. Stock $ilal

2023 Q3 Form 10-Q Financial Statement

#000149315223029488 Filed on August 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL
International Land Alliance Inc. Stock $ilal